Western Blot analysis showed that the levels of apoptotic proteins BAX and BCL2, as well as necroptotic markers RIPK1 and phosphorylated MLKL (p-MLKL), remained unchanged following Lenvatinib treatment in HCC cells (Figure 2g-j). The gene discussed is BCL2; the disease is hepatocellular carcinoma.